Taiho Pharmaceutical, a subsidiary of Otsuka Holdings Co., Ltd., is an R&D-driven specialty pharma focusing on the three fields of oncology, allergy and immunology, and urology. Its corporate philosophy takes the form of a pledge: "We strive to improve human health and contribute to a society enriched by smiles. In the field of oncology in particular, Taiho Pharmaceutical is known as a leading company in Japan for developing innovative medicines for the treatment of cancer, a reputation that is rapidly expanding through their extensive global R&D efforts. In areas other than oncology, as well, the company creates and markets quality products that effectively treat medical conditions and can help improve people's quality of life. Always putting customers first, Taiho Pharmaceutical also aims to offer consumer healthcare products that support people's efforts to lead fulfilling and rewarding lives.
View Top Employees from Taiho Oncology, Inc.Website | https://www.taihooncology.com/us/ |
Revenue | $36 million |
Employees | 12 (11 on RocketReach) |
Founded | 1963 |
Phone | +81 3-3294-4527 |
Fax | (609) 750-7450 |
Industry | Pharmaceuticals, Manufacturing General, Manufacturing |
Web Rank | 136000 |
Web Visits | 484920 |
Keywords | 膵臓癌 初期症状, 胃がん 初期症状, 大腸ガン初期症状, 大腸がん 症状, 製薬会社 森林保護 |
Competitors | Arbor Pharmaceuticals, Archimedes Pharma, QOL Medical LLC, Sanochemia Pharmazeutika, Sinclair Pharma Spain |
SIC | SIC Code 2834 Companies, SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 325413 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Taiho Oncology, Inc. employee's phone or email?
The Taiho Oncology, Inc. annual revenue was $36 million in 2024.
Carolyn Keller is the Senior Director, Sales Operations of Taiho Oncology, Inc..
11 people are employed at Taiho Oncology, Inc..
The NAICS codes for Taiho Oncology, Inc. are [32541, 325413, 325, 32, 3254].
The SIC codes for Taiho Oncology, Inc. are [2834, 28, 283].